Eye care device company Luneau targets Euronext IPO
This article was originally published in Clinica
Executive Summary
French ophthalmic equipment specialist Luneau Technology is aiming to raise funds by floating on the Euronext's Alternext market for small- to medium-sized firms. The Chartres-based firm is offering around 825,000 new shares at a price range of E4.64-5.06 from January 15-28 and expects to begin trading on the Paris branch of the Alternext on February 4. Depending on the demand for its shares, Luneau could exercise an extension option and offer an extra 124,000 shares, as well as a Greenshoe option and offer an additional 82,000 to existing shareholders depending on its performance during its first month on the exchange. The Greenshoe option aims to provide stability to an initial public offering post-pricing. Luneau manufactures various devices and accessories for diagnostic and surgical treatment, including keratometers, tonometers and retinographs. It also makes and sells gynaecology materials.